https://www.cureus.com/articles/183851-transient-intraocular-pressure-fluctuations-after-intravitreal-bevacizumab-injection-in-proliferative-diabetic-retinopathy-patients-a-prospective-study
Introduction: The clinical use of intravitreal bevacizumab (IVB), a recombinant humanized monoclonal antibody that functions as an anti-vascular endothelial growth factor (anti-VEGF), has recently increased in patients with retinal ischemic diseases such as p…
Create an account or login to join the discussion